Arjuna Enters Strategic Collaboration With Pangaea Oncology And The Dr. Rosell Oncology Institute

The research will evaluate Ag5 in treatment-resistant non-small cell lung cancer. Collaboration targets patients who have exhausted Tagrisso® or KRAS inhibitor therapy – an area of critical unmet need with no approved standard of care